» Articles » PMID: 2477703

Cloned Cytotoxic T Cells Recognize an Epitope in the Circumsporozoite Protein and Protect Against Malaria

Overview
Journal Nature
Specialty Science
Date 1989 Sep 28
PMID 2477703
Citations 182
Authors
Affiliations
Soon will be listed here.
Abstract

Protective immunity against malaria is induced by vaccination of hosts with irradiation-attenuated sporozoites. This immunity is mediated in part by neutralizing antibodies that are directed mainly against the repeat domain of the circumsporozoite protein. Early experiments showed, however, that B-cell-depleted mice that are immunized with sporozoites can resist challenge, indicating that T-cell effector mechanisms may also have a role in protection. This idea was supported by the recent observation that protective immunity also requires T-cells expressing the CD8 antigen (CD8+ T cells) whose target is probably the developing liver-stage parasites. Moreover, an oral Salmonella vaccine that expresses the circumsporozoite protein is able to protect against murine malaria in the absence of antibodies. Here we report the identification of an epitope contained within amino acids 249-260 of the Plasmodium berghei circumsporozoite protein that is recognized by H-2Kd-restricted cytotoxic T cells. Passive transfer into mice of cytotoxic-T-cell clones that recognize this epitope conferred a high degree of protection against challenge. These results provide the first direct evidence that CD8+ T cells that are specific for a defined epitope can confer protection against a parasitic infection.

Citing Articles

Generation of a genetically double-attenuated Plasmodium berghei parasite that fully arrests growth during late liver stage development.

Schmid M, Beyeler R, Caldelari R, Rehmann R, Heussler V, Roques M PLoS One. 2024; 19(12):e0316164.

PMID: 39739824 PMC: 11687666. DOI: 10.1371/journal.pone.0316164.


Patient with suspected co-infection of hemorrhagic fever with renal syndrome and malaria: a case report.

Zhao H, Qian H, Wang Z, Ren R, Yu T, Liu H Front Med (Lausanne). 2024; 11:1341015.

PMID: 38751985 PMC: 11094318. DOI: 10.3389/fmed.2024.1341015.


Vaccines and monoclonal antibodies: new tools for malaria control.

Miura K, Flores-Garcia Y, Long C, Zavala F Clin Microbiol Rev. 2024; 37(2):e0007123.

PMID: 38656211 PMC: 11237600. DOI: 10.1128/cmr.00071-23.


Heterogeneity in killing efficacy of individual effector CD8 T cells against Plasmodium liver stages.

Bera S, Amino R, Cockburn I, Ganusov V Proc Biol Sci. 2023; 290(2011):20232280.

PMID: 38018100 PMC: 10685130. DOI: 10.1098/rspb.2023.2280.


Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles.

Nakamae S, Miyagawa S, Ogawa K, Kamiya M, Taniguchi M, Ono A Front Immunol. 2023; 14:1116299.

PMID: 37680630 PMC: 10482405. DOI: 10.3389/fimmu.2023.1116299.